Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I saw that recently in a video about food in Japan. Japanese people going to Western countries and gaining like 25 pounds in a couple of months, then returning to Japan and shedding it within weeks.
Sugar content, portion size, nutrition vs empty calories and other factors…